Workers at the Pfizer plant in Newbridge will be involved in the production of the new experimental anti viral pill for Covid-19, it has emerged.
The US pharma giant said manufacturing facilities at Newbridge and Ringaskiddy will support the global manufacturing and supply of the drug which is awaiting approval.
A spokeswoman told the Leader: “We are pleased to confirm that Pfizer’s manufacturing facilities in Ringaskiddy and Newbridge will support the global manufacturing and supply of our investigational Covid-19 oral antiviral candidate, should it be approved.
“Pfizer has begun investing — prior to regulatory authorization and solely at our own risk and expense — in the manufacture of our potential Covid-19 oral antiviral candidate to help bring this potential treatment to patients as soon as possible.
“Pfizer’s sites in Ringaskiddy and Newbridge have established a successful history of contributing to our manufacturing efforts.
“Tackling the Covid-19 pandemic will likely require both vaccination and targeted treatments for those who contract the virus.
“Pfizer continues to dedicate its best-in-class global resources at all levels to work towards the development of responses to the Covid-19 pandemic, including the development of potential antiviral treatments.”
Subscribe or register today to discover more from DonegalLive.ie
Buy the e-paper of the Donegal Democrat, Donegal People's Press, Donegal Post and Inish Times here for instant access to Donegal's premier news titles.
Keep up with the latest news from Donegal with our daily newsletter featuring the most important stories of the day delivered to your inbox every evening at 5pm.